Strong investor syndicate backs clinical-stage Hepatitis B program while advancing pioneering gene-tuning platform DURHAM, N.C. & SEATTLE–(BUSINESS WIRE)–Leading epigenome editing company Tune Therapeutics… Read More
Study AER-01-002 is using a novel and precision imaging strategy to enroll 100 mucus plug-high chronic obstructive pulmonary disease (COPD) patients AER-01-002 is well powered… Read More
Funding to Advance New Histotripsy Applications and Launch Innovative BOOMBOX Master Study HistoSonics Edison® Histotripsy System (Photo: Business Wire)… Read More
Oversubscribed financing led by strategic investor, with participation from new and existing investors MINNEAPOLIS, June 25, 2024 /PRNewswire/ — Endogenex, a clinical-stage medical device company dedicated to… Read More
Hatteras Venture Partners’ Clay Thorp describes the growth of North Carolina’s biotech industry during his firm’s 20+ years of experience, and describes what the region… Read More
The NACD Research Triangle Chapter, together with RTI International, is delighted to announce a fellowship award in honor of Robert A. Ingram, acknowledging his exceptional… Read More
Acquisition brings access to a novel investigational ß-lactamase inhibitor, expanding pipeline of critically needed antimicrobials, and further augments R&D capabilities and expertise OSAKA, Japan, June… Read More
Financing accelerates MT-302, the Company’s first clinical candidate for in vivo cell programming, into a Phase 1/2 clinical trial for TROP2+ solid tumors CAMBRIDGE,… Read More
For Marco B. Zoccali, MD, FACS, a colorectal surgeon at NewYork-Presbyterian/Columbia, sacral nerve stimulation (SNS) has been a routine part of the care he… Read More
Bob was the most giving of people, who always had the time and focus to make you feel like you were his only concern. As… Read More